Pages that link to "Q39788236"
Jump to navigation
Jump to search
The following pages link to Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis (Q39788236):
Displaying 50 items.
- Ultrasound-guided synovial biopsy: a systematic review according to the OMERACT filter and recommendations for minimal reporting standards in clinical studies (Q26824354) (← links)
- The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses (Q27022645) (← links)
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis (Q27691388) (← links)
- Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system (Q27692640) (← links)
- Ectopic lymphoid neogenesis in rheumatic autoimmune diseases (Q30235935) (← links)
- Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis (Q31078960) (← links)
- B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. (Q33616360) (← links)
- Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab (Q33798060) (← links)
- Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis (Q35687019) (← links)
- A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm (Q35835741) (← links)
- Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection (Q35953366) (← links)
- Is there a role of synovial biopsy in drug development? (Q35994130) (← links)
- Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial (Q36278027) (← links)
- Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure. (Q36401905) (← links)
- Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles (Q36512352) (← links)
- The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? (Q36790324) (← links)
- B-cell targeting: a novel approach to immune intervention today and tomorrow (Q36922233) (← links)
- Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response (Q36930634) (← links)
- B-cell inhibitors as therapy for rheumatoid arthritis: an update (Q36960245) (← links)
- B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis (Q37088694) (← links)
- Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis (Q37106198) (← links)
- Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study (Q37210198) (← links)
- Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis (Q37270745) (← links)
- Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium (Q37324843) (← links)
- Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. (Q37350931) (← links)
- Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results (Q37367847) (← links)
- B-cell-directed therapy for inflammatory skin diseases (Q37369906) (← links)
- Rituximab for the treatment of rheumatoid arthritis: an update (Q37444678) (← links)
- B-cell-directed therapies for autoimmune disease (Q37542901) (← links)
- Targeted therapies in rheumatoid arthritis: Focus on rituximab. (Q37586832) (← links)
- B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis (Q37586921) (← links)
- The role of biomarkers in the management of patients with rheumatoid arthritis (Q37601582) (← links)
- Autoantibodies to posttranslational modifications in rheumatoid arthritis (Q37693939) (← links)
- Synovial tissue response to treatment in rheumatoid arthritis (Q37978861) (← links)
- The problem of choice: current biologic agents and future prospects in RA. (Q38082588) (← links)
- Review on the influence of protocol design on clinical outcomes in rheumatoid arthritis treated with rituximab (Q38085279) (← links)
- B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies (Q38097170) (← links)
- Rituximab biosimilars (Q38100232) (← links)
- An Acquired Defect in IgG-Dependent Phagocytosis Explains the Impairment in Antibody-Mediated Cellular Depletion in Lupus (Q38546315) (← links)
- B cells and their cytokine activities implications in human diseases (Q38665740) (← links)
- Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal? (Q38676903) (← links)
- Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. (Q38842494) (← links)
- Update on the use of rituximab for intractable rheumatoid arthritis. (Q38993240) (← links)
- Pathogenetic insights from the treatment of rheumatoid arthritis (Q39371679) (← links)
- Synovial tissue research: a state-of-the-art review (Q39431367) (← links)
- Rituximab efficiently depletes B cells in lung tumors and normal lung tissue (Q39680704) (← links)
- Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion (Q39708039) (← links)
- Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment (Q40117123) (← links)
- Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab (Q41395989) (← links)
- Living life without B cells: is repeated B-cell depletion a safe and effective long-term treatment plan for rheumatoid arthritis? (Q42229459) (← links)